Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $784.1300 (0.49%) ($784.1300 - $795.9300) on Wed. Aug. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.69% (three month average) | RSI | 76 | Latest Price | $784.1300(0.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.4% a day on average for past five trading days. | Weekly Trend | REGN advances 3.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(53%) IBB(52%) XLF(42%) DIA(41%) SPY(39%) | Factors Impacting REGN price | REGN will decline at least -0.845% in a week (0% probabilities). VXX(-40%) VIXM(-37%) USO(-7%) GLD(-5%) UUP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.845% (StdDev 1.69%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $775.45(1.12%) | 10 Day Moving Average | $758.98(3.31%) | 20 Day Moving Average | $742.79(5.57%) | To recent high | 0% | To recent low | 13.3% | Market Cap | $83.14b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |